Therapeutic effect of Anakinra in the relapsing chronic phase of febrile infection–related epilepsy syndrome

Therapeutic effect of Anakinra in the relapsing chronic phase of febrile infection–related epilepsy syndrome

Summary Febrile infection–related epilepsy syndrome (FIRES) is a severe epileptic encephalopathy with presumed inflammatory origin and lacking effective treatments. Anakinra is the human recombinant interleukin 1 receptor antagonist clinically used in autoinflammatory or autoimmune conditions. We re...

Full description

Bibliographic Details
Main Authors: Robertino Dilena, Eleonora Mauri, Eleonora Aronica, Pia Bernasconi, Cristina Bana, Cristina Cappelletti, Giorgio Carrabba, Stefano Ferrero, Roberto Giorda, Sophie Guez, Stefano Scalia Catenacci, Fabio Triulzi, Sergio Barbieri, Edoardo Calderini, Annamaria Vezzani
Format: Article
Language:English
Published: Wiley 2019-06-01
Series:Epilepsia Open
Subjects:
epileptic encephalopathy
febrile infection–related epilepsy syndrome
IL‐1β
neuroinflammation
Online Access:https://doi.org/10.1002/epi4.12317

Internet

https://doi.org/10.1002/epi4.12317

Similar Items